CVNA (CVNA) insider plans Rule 144 sale of 20,000 common shares

Rhea-AI Filing Summary

CVNA filed a Form 144 notice for a proposed sale of 20,000 shares of its common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $7,995,400. The filing notes that 141,423,193 shares of common stock were outstanding. The seller acquired 10,879 shares on 10/01/2024 via restricted and performance stock units from the issuer and 9,121 shares on 12/08/2025 through a cash exercise of stock options.

Over the past three months, the same person, identified in 10b5-1 sales as Paul Breaux, sold 15,000 common shares on 10/01/2025 for gross proceeds of $5,970,000 and another 15,000 common shares on 09/09/2025 for $5,625,000. By signing, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	7995400.00	141423193	12/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2024	Restricted and Performance Stock Units	Issuer			10879	10/01/2024	N/A
Common	12/08/2025	Exercise of Stock Options	Issuer			9121	12/08/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PAUL BREAUX 300 E. Rio Salado Parkway Tempe AZ 85281	Common	10/01/2025	15000	5970000.00
10b5-1 Sales for PAUL BREAUX 300 E. Rio Salado Parkway Tempe AZ 85281	Common	09/09/2025	15000	5625000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CVNAs latest Form 144 filing disclose?

The Form 144 filing discloses that a holder of CVNA common stock plans to sell 20,000 shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $7,995,400. It also states that 141,423,193 common shares were outstanding.

How many CVNA shares are being proposed for sale and at what market value?

The notice covers a proposed sale of 20,000 common shares of CVNA with an aggregate market value of $7,995,400, to be executed on the NYSE via Morgan Stanley Smith Barney LLC.

How were the CVNA shares in this Form 144 acquired?

The seller acquired 10,879 common shares on 10/01/2024 through restricted and performance stock units from the issuer, and 9,121 common shares on 12/08/2025 via a cash exercise of stock options, also from the issuer.

What prior CVNA stock sales are reported in the last three months?

The filing reports 10b5-1 sales for Paul Breaux of 15,000 common shares on 10/01/2025 for $5,970,000 in gross proceeds and another 15,000 common shares on 09/09/2025 for $5,625,000 in gross proceeds.

Who is named in connection with the CVNA Form 144 and recent sales?

The section on securities sold during the past three months identifies 10b5-1 sales for Paul Breaux, with an address in Tempe, AZ, as the seller of the reported prior common stock transactions.

What representation does the seller make in the CVNA Form 144 notice?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.